NEONC TECHNOLOGIES
NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other nontraditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutics (cancer treatment chemicals) agents. It will initially be used in clinical research for first-line treatment of malignant brain cancer (gliomas) and other aggressive brain cancers, and later for the tr... eatment of lung cancer. NTI was incorporated in the State of Delaware in 2008. The Company has assembled a highly qualified management team and board of directors. NTI is developing several proprietary molecules for clinical research some of which have demonstrated significant activity (positive results) in laboratory tests; NTI is accordingly building a portfolio of intellectual property around this research. In addition, the Company has reached an agreement with a manufacturer of active pharmaceutical ingredients for the development and production of proprietary monoterpenes.
NEONC TECHNOLOGIES
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
2008-01-01
Address:
Woodland Hills, California, United States
Country:
United States
Website Url:
http://www.neonctech.com
Total Employee:
1+
Status:
Active
Contact:
818-971-5100
Total Funding:
150 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.neonctech.com
- Host name: 1330256.cloudwaysapps.com
- IP address: 24.199.126.140
- Location: Flushing United States
- Latitude: 40.7513
- Longitude: -73.8244
- Metro Code: 501
- Timezone: America/New_York
- Postal: 11355
More informations about "NEONC Technologies"
NEONC Technologies - LinkedIn
NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other non traditional delivery of a novel,...See details»
NeOnc Technologies - Crunchbase Company Profile
NeOnc Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers. NeOnc Technologies completed an $18.5 …See details»
Neonc Technologies - PitchBook
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases.See details»
Company Description - Stock Analysis
Jun 12, 2024 · NeOnc Technologies (f/k/a NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical …See details»
NeOnc Technologies Invited to Present at California Investment …
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage biopharmaceutical company, is proud to be presenting at the 2024 California …See details»
Anova Partners With NeOnc Technologies To Bring NEO100 to …
Jun 29, 2021 · NeOnc Technologies, Inc. (NeOnc) is a medical biotechnology company focused on creating novel delivery methods for pharma-based therapeutics that target Brain and …See details»
NeOnc Technologies Engages Anova Enterprises to Pursue
Mar 6, 2023 · Anova Enterprises, a clinical research organization, to prepare FDA Fast Track and Rare Pediatric Designation application for NEO100 ® for Pediatric High-Grade Gliomas …See details»
NeOnc Technologies Completes $10.0 Million Equity Funding Round
Feb 8, 2023 · Funding has Supported Clinical Trials of NEO 100â„¢. LOS ANGELES, Feb. 08, 2023 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage medical …See details»
NeOnc Technologies Holdings Receives FDA Authorization to
Jun 27, 2023 · NeOnc is a privately held clinical-stage biopharmaceutical company focused on creating novel drugs and delivery methods for pharma-based therapeutics that target brain …See details»
NeOnc Technologies Appoints Sidra Medicine CEO and …
Apr 18, 2023 · NeOnc Technologies Holdings is presently a privately held biotechnology company focused on creating novel drugs and delivery methods for pharma-based therapeutics that target brain and...See details»
NeOnc Technologies Formalizes Exclusive Global IP Licensing …
LOS ANGELES, April 24, 2023 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has formally secured exclusive worldwide rights …See details»
NeOnc Technologies CEO and Key Executive Team | Craft.co
NeOnc Technologies's key executives include Amir F. Heshmatpour and 10 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on …See details»
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of - GlobeNewswire
Jul 24, 2024 · NeOnc Technologies is a privately held clinical stage life sciences company focused on the development and commercialization of central nervous system therapeutics …See details»
NeOnc Technologies - News, Layoffs, Mergers & Acquisitions ...
Get the latest news and market signals on NeOnc Technologies, covering its locations, partnerships, sales & lease transactions, major hiring, layoffs, recent acquisitions and many …See details»
NeOnc Technologies Completes $18.5 Million Financing, Advances …
Jun 26, 2024 · Financing supports further expansion of NeOnc’s NEOâ„¢ platform technology that has produced a patent portfolio of novel drug candidates and delivery methods for more …See details»
NeOnc Technologies Completes $10.0 Million Equity Funding
Aug 2, 2023 · NeOnc is a privately held biotechnology company focused on creating novel drugs and delivery methods for pharma-based therapeutics that target brain and central nervous …See details»
NeOnc Technologies - Craft
NeOnc Technologies is a clinical-stage biopharmaceutical company. It specializes in salvage treatment of malignant brain cancer and other aggressive brain cancers. NeOnc Technologies …See details»
NeOnc Technologies Receives FDA Approval to Expand NEO100 …
Jul 16, 2024 · FDA approval reflects positive results from Phase I and preliminary results from Phase IIa study currently underway that demonstrate increased survivability rates in patients …See details»
NeOnc Technologies Begins Enrollment for Phase 2 Clinical
Aug 5, 2024 · NeOnc Technologies is a privately held clinical stage life sciences company focused on the development and commercialization of central nervous system therapeutics …See details»